Strides Arcolab gets US FDA approval for Methotrexate Injection

30 Mar 2012 Evaluate

Strides Arcolab has received US FDA approvals for Methotrexate Injection USP 25 mg/ mL packaged in 1 gram/ 40 m, 50 mg/2 mL, 100 mg / 4 mL, 200 mg/ 8 mL and 250 mg / 10 mL Single dose vials (preservative-free).

Methotrexate is a chemotherapy drug used either alone or in combination with other agents. It is used as a treatment for some autoimmune diseases including rheumatoid arthritis, psoriasis, psoriatic arthritis, lupus and Crohn's disease, to name a few.

Methotrexate is amongst the products in the drug shortage list of US FDA. According to IMS data the US market for generic Methotrexate is approximately USD 13 Million.

Methotrexate is part of the Oncology portfolio licensed to Pfizer in January 2010 for the US market and expected to be launched shortly.

Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.

Strides Pharma Scien Share Price

946.00 5.30 (0.56%)
28-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1522.40
Dr. Reddys Lab 6405.75
Cipla 1482.00
Zydus Lifesciences 1074.35
Lupin 1625.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.